These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21670203)

  • 1. Foxp3-positive macrophages display immunosuppressive properties and promote tumor growth.
    Manrique SZ; Correa MA; Hoelzinger DB; Dominguez AL; Mirza N; Lin HH; Stein-Streilein J; Gordon S; Lustgarten J
    J Exp Med; 2011 Jul; 208(7):1485-99. PubMed ID: 21670203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization.
    Denning TL; Norris BA; Medina-Contreras O; Manicassamy S; Geem D; Madan R; Karp CL; Pulendran B
    J Immunol; 2011 Jul; 187(2):733-47. PubMed ID: 21666057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow CD11b(+)F4/80(+) dendritic cells ameliorate collagen-induced arthritis through modulating the balance between Treg and Th17.
    Zhang L; Fu J; Sheng K; Li Y; Song S; Li P; Song S; Wang Q; Chen J; Yu J; Wei W
    Int Immunopharmacol; 2015 Mar; 25(1):96-105. PubMed ID: 25619457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autofluorescence contributes to false-positive intracellular Foxp3 staining in macrophages: a lesson learned from flow cytometry.
    Li F; Yang M; Wang L; Williamson I; Tian F; Qin M; Shah PK; Sharifi BG
    J Immunol Methods; 2012 Dec; 386(1-2):101-7. PubMed ID: 23046996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth.
    Hansen W; Hutzler M; Abel S; Alter C; Stockmann C; Kliche S; Albert J; Sparwasser T; Sakaguchi S; Westendorf AM; Schadendorf D; Buer J; Helfrich I
    J Exp Med; 2012 Oct; 209(11):2001-16. PubMed ID: 23045606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
    Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
    J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells.
    Klunker S; Chong MM; Mantel PY; Palomares O; Bassin C; Ziegler M; Rückert B; Meiler F; Akdis M; Littman DR; Akdis CA
    J Exp Med; 2009 Nov; 206(12):2701-15. PubMed ID: 19917773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation.
    Robb RJ; Lineburg KE; Kuns RD; Wilson YA; Raffelt NC; Olver SD; Varelias A; Alexander KA; Teal BE; Sparwasser T; Hammerling GJ; Markey KA; Koyama M; Clouston AD; Engwerda CR; Hill GR; MacDonald KP
    Blood; 2012 Jun; 119(24):5898-908. PubMed ID: 22538855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells.
    Haxhinasto S; Mathis D; Benoist C
    J Exp Med; 2008 Mar; 205(3):565-74. PubMed ID: 18283119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory Effect of Imiquimod Through CCL22 Produced by Tumor-associated Macrophages in B16F10 Melanomas.
    Furudate S; Fujimura T; Kambayashi Y; Kakizaki A; Hidaka T; Aiba S
    Anticancer Res; 2017 Jul; 37(7):3461-3471. PubMed ID: 28668835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3.
    Williams LM; Rudensky AY
    Nat Immunol; 2007 Mar; 8(3):277-84. PubMed ID: 17220892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tr1 Cells, but Not Foxp3+ Regulatory T Cells, Suppress NLRP3 Inflammasome Activation via an IL-10-Dependent Mechanism.
    Yao Y; Vent-Schmidt J; McGeough MD; Wong M; Hoffman HM; Steiner TS; Levings MK
    J Immunol; 2015 Jul; 195(2):488-97. PubMed ID: 26056255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery.
    Predina J; Eruslanov E; Judy B; Kapoor V; Cheng G; Wang LC; Sun J; Moon EK; Fridlender ZG; Albelda S; Singhal S
    Proc Natl Acad Sci U S A; 2013 Jan; 110(5):E415-24. PubMed ID: 23271806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells.
    Liu T; Soong L; Liu G; König R; Chopra AK
    Biol Direct; 2009 Oct; 4():40. PubMed ID: 19852824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate.
    Zheng Y; Josefowicz S; Chaudhry A; Peng XP; Forbush K; Rudensky AY
    Nature; 2010 Feb; 463(7282):808-12. PubMed ID: 20072126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral convergence of the TCR repertoires of effector and Foxp3+ CD4+ T cells.
    Kuczma M; Kopij M; Pawlikowska I; Wang CY; Rempala GA; Kraj P
    PLoS One; 2010 Oct; 5(10):e13623. PubMed ID: 21049016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral CD103
    Tanaka Y; Nagashima H; Bando K; Lu L; Ozaki A; Morita Y; Fukumoto S; Ishii N; Sugawara S
    Mucosal Immunol; 2017 Jan; 10(1):79-90. PubMed ID: 27166558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy.
    Obermajer N; Popp FC; Soeder Y; Haarer J; Geissler EK; Schlitt HJ; Dahlke MH
    J Immunol; 2014 Nov; 193(10):4988-99. PubMed ID: 25305313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis.
    Murai M; Turovskaya O; Kim G; Madan R; Karp CL; Cheroutre H; Kronenberg M
    Nat Immunol; 2009 Nov; 10(11):1178-84. PubMed ID: 19783988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.